scispace - formally typeset
R

Richard M. Jay

Researcher at McMaster University

Publications -  25
Citations -  7505

Richard M. Jay is an academic researcher from McMaster University. The author has contributed to research in topics: Thrombosis & Venography. The author has an hindex of 20, co-authored 25 publications receiving 7367 citations.

Papers
More filters
Journal ArticleDOI

A prospective study of venous thromboembolism after major trauma.

TL;DR: Venous thromboembolism is a common complication in patients with major trauma, and effective, safe prophylactic regimens are needed.
Journal ArticleDOI

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

JW tenCate, +113 more
TL;DR: Fixed-dose, subcutaneous low-molecular-weight heparin is as effective and safe as adjusted- dose, intravenous unfractionated Heparin for the initial management of venous thromboembolism, regardless of whether the patient has pulmonary embolism or a history of venOUS thrombolism.
Journal ArticleDOI

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

TL;DR: Low-molecular-weight heparin was more effective than low-dose Heparin in preventing venous thromboembolism after major trauma and both interventions were safe.
Journal ArticleDOI

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

TL;DR: It is indicated that less intense anticoagulant therapy is associated with a low frequency of recurrent venous thromboembolism and a reduced risk of hemorrhage.
Journal ArticleDOI

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

TL;DR: The results of this trial establish the efficacy of intravenous heparin in the treatment of proximal venous thrombosis and suggest a relation between the effectiveness ofHeparin and the levels of anticoagulation achieved; such a relation could explain the observed failure of the subcutaneous regimen.